Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance
From MaRDI portal
Publication:2033746
DOI10.3934/dcdsb.2020245zbMath1498.92058OpenAlexW3081479661MaRDI QIDQ2033746
Zhipeng Qiu, Libin Rong, Qi Deng, Ting Guo
Publication date: 17 June 2021
Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/dcdsb.2020245
Stability of solutions to ordinary differential equations (34D20) Pathology, pathophysiology (92C32)
Related Items (3)
Towards a new combination therapy with vectored immunoprophylaxis for HIV: modeling ``Shock and kill strategy ⋮ Modeling the Effect of Reactive Oxygen Species and CTL Immune Response on HIV Dynamics ⋮ Modeling the effect of activation of CD\(4^+\) T cells on HIV dynamics
Cites Work
- Unnamed Item
- Viral dynamics model with CTL immune response incorporating antiretroviral therapy
- Global stability of a virus dynamics model with Beddington-DeAngelis incidence rate and CTL immune response
- Global properties of a delayed HIV infection model with CTL immune response
- Global stability for a class of virus models with cytotoxic T Lymphocyte immune response and antigenic variation
- Dynamics of a HIV-1 infection model with cell-mediated immune response and intracellular delay
- Complex dynamic behavior in a viral model with delayed immune response
- Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips
- Mathematical biology of HIV infections: Antigenic variation and diversity threshold
- Understanding drug resistance for monotherapy treatment of HIV infection
- A methodology for performing global uncertainty and sensitivity analysis in systems biology
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
- Optimal HIV treatment by maximising immune response
- HIV drug resistance: insights from mathematical modelling
- Modeling the role of acquired immune response and antiretroviral therapy in the dynamics of HIV infection
- Predicting the HIV/AIDS epidemic and measuring the effect of mobility in mainland China
- The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission
- Optimizing within-host viral fitness: infected cell lifespan and virion production rate
- Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility
- Analysis of an HIV model with immune responses and cell-to-cell transmission
- A delay-dependent model with HIV drug resistance during therapy
- A mathematical model for the emergence of HIV drug resistance during periodic bang-bang type antiretroviral treatment
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Global stability in a viral infection model with lytic and nonlytic immune responses
- Estimating kinetic parameters from HIV primary infection data through the eyes of three different mathematical models
- A two-strain HIV-1 mathematical model to assess the effects of chemotherapy on disease parameters
- HIV dynamics: Modeling, data analysis, and optimal treatment protocols
- The dynamics of an epidemic model with targeted antiviral prophylaxis
- Immune Responses and Viral Phenotype: Do Replication Rate and Cytopathogenicity Influence Virus Load?
- Production of resistant HIV mutants during antiretroviral therapy
- Mathematical Modeling of HIV-1 Infection and Drug Therapy
- Optimal Control of an HIV Infection Model with Logistic Growth, CTL Immune Response and Infected Cells in Eclipse Phase
- Stability theory of dynamical systems.
This page was built for publication: Modeling within-host viral dynamics: the role of CTL immune responses in the evolution of drug resistance
